Back
Easterly Government Properties Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
47
DEA
Easterly Government Properties
Last Price:
$23.21
Seasonality Move:
0.25%
Sell
42
APLS
Apellis Pharmaceuticals
Last Price:
$18.84
Seasonality Move:
-0.62%
Sell
47
Easterly Government Properties (DEA)
is a Sell
Is Easterly Government Properties a Buy, Sell or Hold?
-
The current Easterly Government Properties [DEA] share price is $23.23. The Score for DEA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
DEA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $18.83. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DEA Stock Price Chart
What is Easterly Government Properties's stock price today?
-
The Easterly Government Properties share price today is $23.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DEA is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $18.83The current trend is relatively stagnant and APLS is experiencing slight selling pressure.
DEA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 65.21 | Buy |
Chaikin Money Flow: | 11718 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.96 - 22.58) | Buy |
Bollinger Bands (100): | (21.27 - 27.41) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 51.68 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.04 - 19.02) | Buy |
Bollinger Bands (100): | (18.02 - 27.22) | Sell |
DEA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.67 | Buy |
20-day SMA: | 22.03 | Buy |
50-day SMA: | 21.5 | Buy |
200-day SMA: | 28.1 | Sell |
8-day EMA: | 22.76 | Buy |
20-day EMA: | 22.18 | Buy |
50-day EMA: | 22.45 | Buy |
200-day EMA: | 26.49 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.15 | Sell |
20-day SMA: | 18.27 | Buy |
50-day SMA: | 18.45 | Buy |
200-day SMA: | 27.26 | Sell |
8-day EMA: | 19 | Sell |
20-day EMA: | 18.61 | Buy |
50-day EMA: | 19.47 | Sell |
200-day EMA: | 27.34 | Sell |
Easterly Government Properties Earnings Growth & DEA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.
Easterly Government Properties Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |